Ibu-Lysinhexal (Ibuprofen)

Ibuprofen works by reversibly inhibiting the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for the production of prostaglandins. Lower prostaglandin levels result in reduced pain signaling, decreased inflammation, and a lower body temperature during fever.

The appropriate dose of Ibu-Lysinhexal is determined by a prescriber based on the patient’s age, weight, medical condition, and response to therapy. Healthcare professionals tailor the regimen to achieve optimal relief while minimizing risk.

Safety of ibuprofen in pregnancy and lactation depends on the trimester and individual risk factors. It is generally avoided in the third trimester and used only when clearly needed in earlier stages. Breastfeeding mothers should consult a healthcare provider before use.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Ibu-Lysinhexal (ibuprofen) offers a balance of analgesic, antipyretic, and anti‑inflammatory effects with a relatively favorable gastrointestinal safety profile compared with some non‑selective NSAIDs. However, individual response and risk factors vary, so clinicians choose the most appropriate NSAID based on patient history.

Store Ibu-Lysinhexal at ambient temperature, preferably below 25 °C. Keep the product in its original packaging to protect it from moisture and light. Do not store in extreme heat or humidity, and keep out of reach of children.

Ibu-Lysinhexal is taken orally, usually with a full glass of water. It can be taken with or without food, although taking it with food may reduce stomach irritation. The exact administration schedule should follow the prescribing clinician’s instructions.

Serious risks include gastrointestinal bleeding or ulceration, severe allergic reactions such as anaphylaxis, renal impairment, and increased cardiovascular events like heart attack or stroke, especially with high doses or prolonged use. Patients should be monitored for these events.

Individuals with known hypersensitivity to ibuprofen or other NSAIDs, active gastrointestinal ulcers, severe heart failure, uncontrolled hypertension, or those on anticoagulant therapy without medical supervision should avoid Ibu-Lysinhexal. Pregnant women in the third trimester should also refrain from use.